Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

07.08.2017

1 Anticancer Res
1 Br J Cancer
4 Dis Colon Rectum
1 Eur J Cancer
1 Gut
2 Int J Colorectal Dis
1 Int J Oncol
2 J Clin Oncol
2 J Surg Oncol
1 Lancet Oncol
1 PLoS One



    Anticancer Res

  1. YAO HW, Wu GC, Yang YC, Jin L, et al
    Laparoscopic-assisted Transanal Total Mesorectal Excision for Middle-Low Rectal Carcinoma: A Clinical Study of 19 Cases.
    Anticancer Res. 2017;37:4599-4604.
    >> Share


    Br J Cancer

  2. ZHU Y, Wang PP, Zhai G, Bapat B, et al
    Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population.
    Br J Cancer. 2017 Aug 1. doi: 10.1038/bjc.2017.
    >> Share


    Dis Colon Rectum

  3. KOH CE, Solomon MJ, Brown KG, Austin K, et al
    The Evolution of Pelvic Exenteration Practice at a Single Center: Lessons Learned from over 500 Cases.
    Dis Colon Rectum. 2017;60:627-635.
    >> Share

  4. WEXNER SD, Berho ME
    The Rationale for and Reality of the New National Accreditation Program for Rectal Cancer.
    Dis Colon Rectum. 2017;60:595-602.
    >> Share

  5. HABR-GAMA A, Sao Juliao GP, Gama-Rodrigues J, Vailati BB, et al
    Baseline T Classification Predicts Early Tumor Regrowth After Nonoperative Management in Distal Rectal Cancer After Extended Neoadjuvant Chemoradiation and Initial Complete Clinical Response.
    Dis Colon Rectum. 2017;60:586-594.
    >> Share

  6. KUSTERS M, Slater A, Muirhead R, Hompes R, et al
    What To Do With Lateral Nodal Disease in Low Locally Advanced Rectal Cancer? A Call for Further Reflection and Research.
    Dis Colon Rectum. 2017;60:577-585.
    >> Share


    Eur J Cancer

  7. TOPI G, Ehrnstrom R, Jirstrom K, Palmquist I, et al
    Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer.
    Eur J Cancer. 2017;83:279-289.
    >> Share


    Gut

  8. ADAMS LA, Anstee QM, Tilg H, Targher G, et al
    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
    Gut. 2017;66:1138-1153.
    >> Share


    Int J Colorectal Dis

  9. COLLOCA G, Venturino A
    Erratum to: Role of family history and tumor location on prognosis of patients with colorectal cancer and synchronous metastases.
    Int J Colorectal Dis. 2017 Aug 2. doi: 10.1007/s00384-017-2877.
    >> Share

  10. COSTA G, Lorenzon L, Massa G, Frezza B, et al
    Emergency surgery for colorectal cancer does not affect nodal harvest comparing elective procedures: a propensity score-matched analysis.
    Int J Colorectal Dis. 2017 Jul 28. doi: 10.1007/s00384-017-2864.
    >> Share


    Int J Oncol

  11. SZARYNSKA M, Olejniczak A, Wierzbicki P, Kobiela J, et al
    FasR and FasL in colorectal cancer.
    Int J Oncol. 2017;51:975-986.
    >> Share


    J Clin Oncol

  12. GARG MK, Zhao F, Sparano JA, Palefsky J, et al
    Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).
    J Clin Oncol. 2017;35:718-726.
    >> Share

  13. SPARANO JA, Lee JY, Palefsky J, Henry DH, et al
    Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.
    J Clin Oncol. 2016 Dec 12:JCO2016691642.
    >> Share


    J Surg Oncol

  14. SHO S, Court CM, Winograd P, Russell MM, et al
    A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24781.
    >> Share

  15. MAHAR AL, Compton C, Halabi S, Hess KR, et al
    Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.
    J Surg Oncol. 2017 Aug 2. doi: 10.1002/jso.24774.
    >> Share


    Lancet Oncol

  16. KUBOKI Y, Nishina T, Shinozaki E, Yamazaki K, et al
    TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study.
    Lancet Oncol. 2017 Jul 28. pii: S1470-2045(17)30425.
    >> Share


    PLoS One

  17. ZHANG Y, Liu H, Li L, Ai M, et al
    Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2017;12:e0181852.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016